Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pregnant Women Can Now Test for Amniotic Fluid Leakage at Home

By HospiMedica International staff writers
Posted on 29 Aug 2008
A new at-home screening for amniotic fluid leakage during pregnancy could help control a condition that may lead to serious complications such as infections and preterm labor.

The AmniScreen home detection kit is located in a panty liner, and is intended for pregnant women who experience unexplained vaginal wetness. More...
Other potential candidates include high-risk pregnant women, women who have undergone amniocentesis, women who have experienced prior amniotic fluid leakage, and those who are concerned about unexplained wetness. Each AmniScreen test kit contains three panty liners and three drying trays, offering screening in any location. The system works by detecting elevated pH levels, which may indicate amniotic fluid leakage; a pH level greater than or equal to 5.2 produces a blue-green color. Patients are then instructed to report the test results to their healthcare provider for interpretation and medical care. The test should not be used if less than 12 hours have passed since sexual intercourse or vaginal douching, and if there is vaginal bleeding or spotting. The AmniScreen home detection kit is a product of Barr Pharmaceuticals (Montvale, NJ, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"It's important to know when wetness may be caused by amniotic fluid leakage,” said Nancy Jasper, M.D., an assistant clinical professor of obstetrics and gynecology at Columbia University (New York, NY, USA). "This new tool provides pregnant women with an effective way to identify unexplained wetness, with easy-to-read results that should be discussed with their healthcare provider. This important new test is an additional resource which may provide healthcare providers with information to help determine the necessity of a patient hospital or office visit.”

Over 20% of women arriving at the hospital due to wetness they suspect to be caused by amniotic fluid leakage are sent back home after verifying the cause of the wetness is urine (many third trimester pregnancies are accompanied with urine incontinence, specifically when coughing or laughing). On the other hand, many pregnant women do not react to initial amniotic fluid leakage, as they are sure the wetness they sense is from urine incontinence or vaginal discharge, endangering both themselves and the fetus.

Related Links:
Barr Pharmaceuticals


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.